Skip to content

WHO spells out how d4T dose reduction should be implemented

Levels of albumin in urine higher in people with HIV, association with risk of heart and kidney disease

Tenofovir and Truvada — what to do with them if you can get your hands on them?

Epidemic of cardiovascular disease in HIV patients `not on horizon`

No major metabolic differences between PI-based and NNRTI-based therapies in five-year trial

Dose modification associated with poorer response to HCV therapy in HIV/HCV coinfected patients

HIV infection doubles risk of heart attack in US patients; risk trebled in women

AZT causes genetic damage to infants; long-term cancer risk unknown

Toxicity of nevirapine-based ART differs in pregnant HIV-infected Mozambican and Thai women with higher CD4 counts